Unlocking the Medical Potential of Cannabis
From Plant
Drive genetic diversity and tracebility to deliver therapy-specific cultivars
To Therapy
Curate a clinical research & development platform to accelerate the development of Cannabis-based finished drugs
To Market
Secure compliance & market access to distribute high quality cannabis medicines in EU
To Patient
Capture patient reported outcomes to enable personalised therapies.
We are Cannaflos, a European medical Cannabis company.
We are specialised in research and development of Cannabis genetics and sponsor finished drug development of Cannabis-based medicines.
We serve the value chain of medical cannabis with expertise in cultivation, production, clinical research, compliance and regulatory affairs.
We serve your needs across the Cannabis value chain
Our end-to-end capabilities
Cultivate one of our 14 fully traceable premium Cannabis genetics. They have been carefully developed for their unique cannabinoid composition, cultivation procedures and morphology.
Custom Cultivar Development
Benefit from our proven track record in cultivar development and registry to develop unique genetics, customised to your needs.
We engage our expertise, partners and network in Cannabis-based clinical research to accelerate your finished drug development process.
We help you achieve your GACP & EU-GxP license. Our in-house Qualified person has deep Cannabis expertise, covering a wide range of compliance and product quality advisory.
Cannaflos has the necessary manufacturing license to act as a pharmaceutical entrepreneur in the EU, enabling us to release products and act as wholesalers.
We are research-driven
The Cannabis plant remains largely under-researched, locking in its medical potential and leaving room for stigma and legal barriers.
At Cannaflos, we believe good science means good business. Therefore, we pursue an evidence based approach across all our business endeavours. We are commited to unlock the medical potential of Cannabis by conducting research into the genetics of the plant and reveal its therapeutic potential in clinical trails.
To do so, our in-house scientists work hand in hand with top-tier academic and clinical researchers around the world to advance our knowledge for the benefit of the plant, the patient and the planet.
Shaping the future of medical Cannabis, together
Cannaflos works closely with international partners in cultivation, manufacturing, research and development, and regulatory affairs. We see a special potential in European cooperation. Through harmonised processes and quality standards Cannaflos and its partners can promote international research and development in the field of medical cannabis under fair business conditions.
Leveraging business as a force for good
Licensed GDP-Wholesaler according to §52a AMG & §3 BtMG
Our innovative approach is promoted by
